Roberts JA - Search Results

1

Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.

Roberts JA, Kwa A, Montakantikul P, Gomersall C, Kuti JL, Nicolau DP. Roberts JA, et al. Int J Antimicrob Agents. 2011 Mar;37(3):225-9. doi: 10.1016/j.ijantimicag.2010.10.024. Epub 2010 Dec 18. Int J Antimicrob Agents. 2011. PMID: 21168997

2

Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.

Roberts JA, Boots R, Rickard CM, Thomas P, Quinn J, Roberts DM, Richards B, Lipman J. Roberts JA, et al. Among authors: roberts dm. J Antimicrob Chemother. 2007 Feb;59(2):285-91. doi: 10.1093/jac/dkl478. Epub 2006 Nov 28. J Antimicrob Chemother. 2007. PMID: 17135183 Clinical Trial.

3

Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.

Roberts JA, Webb SA, Lipman J. Roberts JA, et al. Int J Antimicrob Agents. 2007 Feb;29(2):117-28. doi: 10.1016/j.ijantimicag.2006.08.031. Epub 2006 Dec 8. Int J Antimicrob Agents. 2007. PMID: 17158033 Review.

4

Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.

Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J. Roberts JA, et al. Int J Antimicrob Agents. 2007 Jul;30(1):11-8. doi: 10.1016/j.ijantimicag.2007.02.002. Epub 2007 Apr 17. Int J Antimicrob Agents. 2007. PMID: 17442541 Review.

5

A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis.

Roberts JA, Roberts MS, Robertson TA, Cross SE, Lipman J. Roberts JA, et al. Among authors: roberts ms. Int J Antimicrob Agents. 2008 Mar;31(3):240-4. doi: 10.1016/j.ijantimicag.2007.09.013. Epub 2007 Dec 4. Int J Antimicrob Agents. 2008. PMID: 18054829

6

Optimizing use of beta-lactam antibiotics in the critically ill.

Roberts JA, Lipman J. Roberts JA, et al. Semin Respir Crit Care Med. 2007 Dec;28(6):579-85. doi: 10.1055/s-2007-996404. Semin Respir Crit Care Med. 2007. PMID: 18095221 Review.

7

Antibiotic resistance--what's dosing got to do with it?

Roberts JA, Kruger P, Paterson DL, Lipman J. Roberts JA, et al. Crit Care Med. 2008 Aug;36(8):2433-40. doi: 10.1097/CCM.0b013e318180fe62. Crit Care Med. 2008. PMID: 18596628 Review.

8

Pharmacokinetic issues for antibiotics in the critically ill patient.

Roberts JA, Lipman J. Roberts JA, et al. Crit Care Med. 2009 Mar;37(3):840-51; quiz 859. doi: 10.1097/CCM.0b013e3181961bff. Crit Care Med. 2009. PMID: 19237886 Review.

9

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Roberts JA, et al. Among authors: roberts ms. J Antimicrob Chemother. 2009 Jul;64(1):142-50. doi: 10.1093/jac/dkp139. Epub 2009 Apr 27. J Antimicrob Chemother. 2009. PMID: 19398460 Clinical Trial.

10

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.

Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. Roberts JA, et al. Among authors: roberts ms. Int J Antimicrob Agents. 2010 Feb;35(2):156-63. doi: 10.1016/j.ijantimicag.2009.10.008. Epub 2009 Dec 16. Int J Antimicrob Agents. 2010. PMID: 20018492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,521 results

Search Page

Filters